
Understanding, Diagnosing, and Using Genetic Testing for Epidermolysis Bullosa
Learn about the role of genetic testing in diagnosing Epidermolysis Bullosa. Discover types, symptoms, and how genetic insights lead to tailored treatment plans.

MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.

Learn about the role of genetic testing in diagnosing Epidermolysis Bullosa. Discover types, symptoms, and how genetic insights lead to tailored treatment plans.

Unravel Epidermolysis Bullosa Dystrophica: symptoms, diagnosis, and genetic testing. Learn how genetic insights guide personalized treatment and family planning.

Explore Episodic Ataxia Type 2, a rare neurological disorder. Learn about its symptoms, genetic testing for CACNA1A mutations, and effective treatments like flunarizine.

Esophageal squamous cell carcinoma insights: symptoms, diagnosis, and the critical role of genetic testing in tailoring treatments, monitoring, and risk assessment.

Familial Hypercholesterolemia (FH) leads to high cholesterol and cardiovascular risks. Genetic testing confirms FH, guides treatments, and identifies at-risk family members.

Familial Visceral Amyloidosis, Ostertag Type (FVAO) is a rare, inherited disorder characterized by the abnormal deposition of amyloid proteins in various organs.

Unlock the potential of genetic testing in diagnosing Frontotemporal Dementia (FTD) and Amyotrophic Lateral Sclerosis (ALS). Learn how TBK1 mutations impact these conditions.

G6PD deficiency affects red blood cells, leading to hemolytic anemia. Learn about diagnosis, genetic testing, and management of this hereditary condition effectively.